Bone density in Type 1 Gaucher disease

被引:0
|
作者
Pastores, GM
Wallenstein, S
Desnick, RJ
Luckey, MM
机构
[1] MT SINAI SCH MED,DEPT HUMAN GENET,NEW YORK,NY 10029
[2] MT SINAI SCH MED,DEPT PEDIAT,NEW YORK,NY 10029
[3] MT SINAI SCH MED,DEPT BIOMATH,NEW YORK,NY 10029
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Skeletal involvement is a major source of complications in patients with Type 1 Gaucher disease. To investigate the bone density and potential usefulness of bone densitometry in Gaucher disease? dual-energy X-ray absorptiometry was used to measure the density of the lumbar spine, femoral neck, trochanter, and distal radius in 61 adult patients ranging in age from 22 to 77 years, The mean bone density at each site was significantly lower than expected for age and sex, The severity of the osteopenia correlated significantly with other clinical indicators of disease severity, including the N370S/84GG genotype, prior splenectomy, and hepatomegaly, The bone density measurements also correlated significantly,vith the severity of skeletal disease as assessed by skeletal radiography, Vertebral density remained an independent predictor of the severity of bone involvement even after controlling for age, sex weight, genotype, splenectomy, and hepatomegaly, These findings suggest that bone density measurements provide a quantitative assessment of bone involvement in Type 1 Gaucher disease, which may permit serial, noninvasive monitoring of bone changes in this progressive disorder.
引用
收藏
页码:1801 / 1807
页数:7
相关论文
共 50 条
  • [41] CORRELATION BETWEEN BONE DISEASE AND GENOTYPE IN PATIENTS WITH GAUCHER DISEASE TYPE 1. DATA FROM THE SPANISH REGISTER OF GAUCHER'S DISEASE
    Andrade Campos, M.
    Valero, E.
    Roca Espiau, M.
    Giraldo, P.
    HAEMATOLOGICA, 2017, 102 : 239 - 239
  • [42] High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease
    Taddei, Tamar H.
    Dziura, James
    Chen, Shu
    Yang, Ruhua
    Hyogo, Hideyuki
    Sullards, Cameron
    Cohen, David E.
    Pastores, Gregory
    Mistry, Pramod K.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (03) : 291 - 300
  • [43] The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease
    Cohen, I. J.
    CLINICAL GENETICS, 2007, 72 (02) : 160 - 160
  • [44] Gaucher disease and bone
    Mikosch, P.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2011, 25 (05): : 665 - 681
  • [45] The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease
    Charrow, J.
    Dulisse, B.
    Grabowski, G. A.
    Weinreb, N. J.
    CLINICAL GENETICS, 2007, 71 (03) : 205 - 211
  • [46] The bone in Gaucher disease
    Weinreb, Neal J.
    CLINICAL THERAPEUTICS, 2007, 29 : S91 - S92
  • [47] Bone lesions in type 1 Gaucher disease after improving dose and compliance with imiglucerase
    Soberon, Barbara C.
    Fernandez Escobar, Nicolas
    Basack, Nora
    Detoni, Debora
    Larroude, Maria Silvia
    Aguilar, Gabriel
    Rossi, Ignacio
    Watman, Nora
    Dragosky, Marta
    Schenone, Andrea
    Drelichman, Guillermo
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S134 - S134
  • [48] Aberrant bone marrow vascularization patterns in untreated patients with Gaucher disease type 1
    Klimkowska, Monika
    Machaczka, Maciej
    Palmblad, Jan
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 54 - 59
  • [49] A Comprehensive Study of Bone Manifestations in Adult Gaucher Disease Type 1 Patients in Argentina
    Beatriz Oliveri
    Diana González
    Felisa Quiroga
    Claudio Silva
    Paula Rozenfeld
    Calcified Tissue International, 2019, 104 : 650 - 657
  • [50] SERUM ACID-PHOSPHATASE AND BONE INVOLVEMENT IN TYPE-1 GAUCHER DISEASE
    CHOY, F
    AMERICAN JOURNAL OF HUMAN GENETICS, 1983, 35 (06) : A39 - A39